Rxcurve
HCPCS Q5121 · per 10 MG

Inj. avsola, 10 mg

Products billed under this code include Avsola.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under Q5121

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Avsola Amgen Inc 55513-0670-01 10 $346.86
Avsola Amgen Inc 55513-0670-21 10 $346.86

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $34.686 +$3.856 10 MG Inj. avsola, 10 mg v1, posted September 17, 2026
3Q26 $30.83 +$2.79 10 MG Inj. avsola, 10 mg v1, posted September 15, 2026
2Q26 $28.04 +$4.229 10 MG Inj. avsola, 10 mg v1, posted September 15, 2026
1Q26 $23.811 +$3.406 10 MG Inj. avsola, 10 mg v1, posted September 15, 2026
4Q25 $20.405 −$0.481 10 MG Inj. avsola, 10 mg v1, posted September 8, 2026
3Q25 $20.886 +$1.137 10 MG Inj. avsola, 10 mg v1, posted March 10, 2026
2Q25 $19.749 −$0.076 10 MG Inj. avsola, 10 mg v1, posted March 10, 2026
1Q25 $19.825 −$1.465 10 MG Inj. avsola, 10 mg v1, posted December 19, 2025
4Q24 $21.29 −$0.599 10 MG Inj. avsola, 10 mg v1, posted June 11, 2025
3Q24 $21.889 −$2.484 10 MG Inj. avsola, 10 mg v1, posted June 11, 2025
2Q24 $24.373 −$1.182 10 MG Inj. avsola, 10 mg v1, posted March 11, 2025
1Q24 $25.555 −$0.913 10 MG Inj. avsola, 10 mg v1, posted December 19, 2024
4Q23 $26.468 −$1.866 10 MG Inj. avsola, 10 mg v1, posted October 10, 2024
3Q23 $28.334 −$0.125 10 MG Inj. avsola, 10 mg v1, posted June 5, 2024
2Q23 $28.459 −$5.043 10 MG Inj. avsola, 10 mg v1, posted February 23, 2024
1Q23 $33.502 −$2.917 10 MG Inj. avsola, 10 mg v1, posted December 6, 2023
4Q22 $36.419 −$2.23 10 MG Inj. avsola, 10 mg v1, posted June 22, 2023
3Q22 $38.649 −$4.641 10 MG Inj. avsola, 10 mg v1, posted June 9, 2023
2Q22 $43.29 −$2.014 10 MG Inj. avsola, 10 mg v1, posted December 14, 2022
1Q22 $45.304 −$1.813 10 MG Inj. avsola, 10 mg v1, posted June 8, 2022
4Q21 $47.117 −$2.035 10 MG Inj. avsola, 10 mg v1, posted June 2, 2022
3Q21 $49.152 −$0.909 10 MG Inj. avsola, 10 mg v1, posted June 2, 2022
2Q21 $50.061 −$1.439 10 MG Inj. avsola, 10 mg v1, posted March 1, 2022
1Q21 $51.50 – 10 MG Inj. avsola, 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files